TUSC3 and pancreatic neoplasm: To sum up, the current study shows that decreased immunohistological TUSC3 staining is a factor prognostic of poor survival in pancreatic cancer patients, TUSC3 down-regulation may be connected with enhanced NF-κB activity, and decreased TUSC3 promotes pancreatic cancer cell proliferation, invasion and metastasis.